| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Windtree Therapeutics Inc /de/ (WINT) has 0 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. WINT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 8, 2024 | Fraser Craig | President And CEO | Buy | 5,431 | $0.91 | $4,941.67 | +169.3% | |
| Sep 27, 2023 | Fraser Craig | President And CEO | Buy | 2,500 | $1.02 | $2,549.75 | +4.5% | |
| Sep 26, 2023 | Fraser Craig | President And CEO | Buy | 2,500 | $0.90 | $2,250.00 | +4.7% | |
| Apr 26, 2023 | Fraser Craig | President And CEO | Buy | 1,497 | $1.77 | $2,649.69 | +27.2% | |
| Apr 25, 2023 | Fraser Craig | President And CEO | Buy | 1,315 | $1.89 | $2,485.35 | +31.3% | |
| Jul 27, 2022 | Fraser Craig | President And CEO | Buy | 2,500 | $0.38 | $949.75 | +1.1% | |
| Jul 26, 2022 | Hamill John P. | SVP &CFO | Buy | 3,000 | $0.37 | $1,099.80 | +4.3% | |
| Jul 26, 2022 | Fraser Craig | President And CEO | Buy | 2,500 | $0.37 | $935.00 | +1.1% | |
| Jun 30, 2022 | Fraser Craig | President And CEO | Buy | 4,500 | $0.43 | $1,925.55 | +2.1% | |
| Jun 29, 2022 | Fraser Craig | President And CEO | Buy | 7,000 | $0.42 | $2,907.80 | +3.3% |